INTRODUCTION
Determining the key position that Ca2l holds in controlling many cellular pathways has been greatly aided by the availability of Ca2+ ionophores such as A23187 and ionomycin. Given the earlier studies in cells and artificial membranes (Pressman, 1976; Pressman and Fahim, 1982) , it has generally been assumed that these antibiotics directly facilitate the transport of Ca2+ across the plasma membrane, circumventing natural entry pathways. However, more recently, some reports have suggested this assumption may be incorrect: in bovine adrenal chromaffin cells (Stauderman and Pruss, 1989) and fibroblasts (Byron et al., 1992) , ionomycin mobilized intracellular Ca2+ stores without stimulating a Ca2+ influx. Similarly, studies in pituitary cell lines suggested that ionomycin primarily discharged the agonistsensitive Ca2+ pools, whereas the smaller Ca2+-influx component was assumed to be due to ionophore action at the plasma membrane Tashjian, 1984, 1986) . Furthermore, ionomycin-induced cation entry in human umbilical-vein endothelial cells (HUVEC) may share a common route of entry with histamine-induced entry, since both responses were inhibited by thrombin (Neylon and Irvine, 1991) . On the other hand, others have shown that inhibitors of Ca2+ entry such as SK&F 96365 (Davies et al., 1992; Graier et al., 1992) or phorbol ester (McCarthy et al., 1989) had no effect on ionophore responses, while decreasing agonist-driven effects, which is more consistent with the ionophores directly translocating bivalent cations across the plasma membrane.
We have undertaken a more rigorous examination of ionomycin stimulation of Ca2+ influx in a HUVEC-derived cell line, ECV304. This is a spontaneously transformed cell line that peak [Ca2+] , response unaffected). In other experiments, although addition of ionomycin further increased the plateau phase induced by 100 ,uM histamine, the increase was completely abolished by pretreatment with the store Ca2+-ATPase inhibitor cyclopiazonic acid (CPA). Furthermore, in store-depleted cells, re-addition of 1 mM extracellular Ca2+ (in the presence of CPA plus histamine) led to a rapid rise in [Ca2+]1, dependent on Ca2+ influx, with kinetics that were not enhanced by ionomycin. These data suggest that ionomycin acts primarily at the level of the internal Ca2+ stores, so that, at the concentrations used here (< 1 uM), it increases Ca2+ (and Mn2+) influx via activation of endogenous entry pathways and not by plasmalemmal translocation.
resembles endothelial cells in several aspects, including antigenic markers, polyamine uptake and endothelial-specific enzymes (Takahashi et al., 1990) . In this paper, we show that apparent ionomycin-mediated translocation of cations across the plasma membrane is by a store-regulated Ca2+-influx mechanism Jacob, 1990; Schilling et al., 1992) and not the expected ionophore action at the plasma membrane.
MATERIALS AND METHODS Materials
Fura-2/AM and fura-2 (penta-potassium salt) were from Molecular Probes (Eugene, OR, U.S.A.). Hepes (free acid), cyclopiazonic acid (CPA) and ionomycin were from Calbiochem. Histamine phosphate, digitonin, pyrilamine and BSA (fraction V) were from Sigma (Poole, Dorset, U.K.). EGTA was obtained from Fluka at puriss. grade. SK&F 96365 (1-{fl-[3-(4-methoxyphenyl) propoxy]-4-methoxyphenethyl}-1H-imidazole hydrochloride) was given by Dr. Paul England, SmithKline Beecham, Welwyn, Herts., U.K. All other reagents were from Sigma, Fisons and BDH at the equivalent of AnalaR grade.
Cell culture
The HUVEC line ECV304 was obtained from Dr. Kimiko Takahashi (Department of Biochemistry, National Defense Medical College, Saitama, Japan) and used between passages 90 and 120. Cells were cultured in Medium 199 supplemented with 10 % foetal-calf serum, 2 mM L-glutamine, 50 i.u./ml penicillin and 50 ,g/ml streptomycin, and passaged by using trypsin/ Fura-2 was loaded by incubating cells in 80 % Dulbecco's Modified Eagle's Medium/20 % foetal-calf serum with 2 uM fura-2/AM at room temperature for 60 min, after which the cells were maintained at room temperature in balanced salt solution (BSS) supplemented with 1 % (w/v) BSA before use (< 3 h after loading). The BSS composition was (mM): NaCl 145, KC1 5, MgSO4 1, CaCl2 1, Hepes 10, glucose 10, BSA 0.1 % (w/v), pH 7.4. Measurement of [Ca2+] , was performed essentially as described previously (Jacob, 1990) , by using epifluorescence microscopy, or a similar system connected to a Cairn cuvette holder for population studies. The rate of data acquisition was generally 2 Hz, except in those stated instances where a 5 Hz collection rate was employed. The entry of Mn2+ was inferred from the quenching of fluorescence at 360 nm, the isoemissive wavelength for fura-2 with respect to Ca2+ (Meritt et al., 1989) . At the end of each run, autofluorescence was estimated by addition of 0.5-1 ,uM ionomycin and 2 mM Mn2+ (or 8 mM when 2 mM EGTA was present), which quenches fura-2 and calibrated as described by Grynkiewicz et al. (1985) .
Data were usually converted into [Ca2+]1, except for the data reported in Figures 1, 2 the CPA and ionomycin responses became more sustained, indicating a Ca2+ influx (Demaurex et al., 1992; Schilling et al., 1992) . The nature of the intracellular store(s) that these two agents were mobilizing was examined by completely discharging the agonist-sensitive store with 100 1tM histamine in Ca2+-free solution (Figure 2a : histamine followed by ionomycin). This had the effect of substantially decreasing the subsequent ionomycinand CPA-evoked changes in 350/380 nm fluorescence ratio, expressed as a percentage of the initial histamine peak response [ionomycin 13.4+3.6% (n = 5); CPA 17.0+3.5% (n = 4); P < 0.0002 and P < 0.02 respectively (paired, one-tailed)]. Similarly, when the order of addition was reversed (Figure 2b : ionomycin followed by histamine), depletion of stores by ionomycin or CPA inhibited the histamine peak, expressed as a percentage of the initial peak response [ionomycin depletion 26.8+3.9% (n=7); CPA depletion 11.4+2.8% (n=4); P < 0.0001 and P < 0.005 respectively]. These observations suggest that all three agents mobilize the same intracellular Ca2+ pools. The ability of ionomycin and CPA to elevate [Ca2+] , slightly, even after histamine-induced store depletion, does not necessarily suggest that there is more than one store: re- The concentration-response relationship to ionomycin was established in single cells by using the response to 100 1tM histamine as a reference (see Figure 3 legend). Figure 3 shows saturation of the peak ionomycin response at 0.5-1 ,uM (EC5 0.3 , uM) (Figure 3a) , where the large errors indicate the inherent variability in the responses in individual cells. Saturation of the plateau phase of the response is also achieved by addition of 1 ,tM ionomycin, since there is no further effect of repeated additions of ionomycin beyond 1 ,uM in populations of cells (Figure 3b Stimulation of Mn2+ entry after store depletion Given that both CPA and ionomycin could discharge the agonist-sensitive pool, we next examined whether they could, in turn, trigger cation influx in a manner analogous to histamine (Jacob, 1990) . The unidirectional entry of Mn2 , monitored by the quenching of fura-2, has frequently been used as an index for stimulated cation entry Jacob, 1990; Montero et al., 1990; Neylon and Irvine, 1991; Davies et al., 1992) . Figure 4 indicates the ability of histamine, ionomycin and CPA to stimulate Mn2+ influx by depletion of internal stores in Ca2+-free solution. As has been observed previously (Jacob, 1990) , histamine activated Mn2+ influx even after the removal of agonist. Moreover, once a rate of quench was established, the addition of ionomycin did not alter this rate of Mn2+ entry (pre-ionomycin 0.0 149 + 0.0023 V/s; post-ionomycin 0.0151 + 0.0020 V/s; paired two-tailed, P> 0.9, n = 10) (Figure 4a) . Similarly, when ionomycin was used to deplete stores, and then removed, a stimulation of Mn2+ entry was again seen, which was not significantly enhanced upon addition of histamine (pre-histamine 0.0152+0.0030 V/s; post-histamine 0.0273+0.0051 V/s; P > 0.05, n = 8) (Figure 4b ), although in these experiments the responses were somewhat more variable, with 3/8 cells exhibiting an enhancement of the quench rate with histamine. Similarly, no significant effect was observed upon ionomycin-stimulated Mn2+ entry if ionomycin itself was re-applied instead of histamine (pre-ionomycin re-application 0.0127 +0.0019 V/s; post-ionomycin re-application 0.0123 + 0.0012 V/s; P > 0.7, n = 6) ( Figure 4c ). To strengthen further the idea that store depletion activated Mn2+ entry, refilling the intracellular pools after ionomycin removal by a 2 min exposure to 1 mM Ca 2+ substantially decreased the stimulated rate of quench [85 + 20% inhibition; n = 13, P < 0.0001 (paired, two-tailed)]. In other experiments, CPA also activated Mn2+ entry. However, the effect of histamine on this stimulated Mn2+-entry rate was somewhat variable. In some cells histamine had little effect on the rate of quench (n = 2) (Figure 4d) is mediated by such a mechanism, SK&F 96365 should inhibit the response. Indeed, when fura-2 quenching in single or small groups of cells was measured, 75 Table 2 ). Traces are typical of 8-9 experiments performed on the same batch of cells. To confirm that increases in influx rate could be seen by using this protocol, stores were depleted as described above with a combination of histamine and CPA, and 3 or 10 mM CaCl2 was applied. Although no significant increase in the rate of rise was observed with 3 mM Ca2+0, an approx. 3-fold increment in rate of rise was seen with 10 mM Ca2+,, confirming the previously reported non-linear relationship between rate ofinflux and [Ca2+]o in endothelial cells (Schilling et al., 1989) .
DISCUSSION
The purpose ofthis study was to define the mechanism underlying ionomycin-stimulated cation influx in human endothelial cells. A wealth of evidence has accumulated to suggest that agoniststimulated Ca2+-influx in a variety ofcell types, including vascular endothelial cells (and HUVEC in particular) , is a consequence of store depletion itself and not merely the activation of receptors Jacob, 1990; Schilling et al., 1992) . Therefore, our working hypothesis was that ionomycin-stimulated Ca2+ influx might be due to SRCE.
One major Ca2+ pool In ECV304 cells
In the absence of extracellular Ca2+, histamine, ionomycin and CPA clearly discharge internal stores which appear to be common to all three agents. In this regard, the ECV304 cell line resembles bovine aortic endothelial cells (Schilling et al., 1989) , whereas PC12 cells (Fasolato et al., 1991) and rat parotid acinar cells (Merritt and Rink, 1987) appear to possess more than one intracellular store distinguishable by their accessibility to pharmacological agents. Although others have shown that Ca2+-ATPase inhibitors can distinguish subsets of intracellular Ca2+ pools (Robinson et al., 1992; R0tnes and Iversen, 1992; Islam and Berggren, 1993) , which may reflect the inhibitor-sensitivity of some Ca2+-ATPase isoforms (Papp et al., 1992) , we cannot infer that there is only one homogeneous pool, since the ability of CPA to distinguish ATPase populations is not well characterized.
Store-regulated Mn2+ influx
Consistent with the capacitance model for the regulation of Ca2+ entry , we have shown that depletion of the stores by histamine, ionomycin and CPA stimulates Mn 2 influx, as has been demonstrated in other cell types (Jacob, 1990; Schilling et al., 1992) , and by a mechanism which is shared by all three agents: in additivity experiments, the rate of ionomycinstimulated Mn2+ entry was unaffected by agonist, suggesting that no additional entry pathways are recruited by histamine over and above those invoked by store discharge (at least, that are detectable by this protocol). Complementary to this, the rate of rise in [Ca2+]1 (equivalent to Ca2+ influx) was unaffected by the presence of histamine, which suggests that there is no major Ca2+-specific entry pathway coupled tightly to receptors that is not detected by Mn2' quenching (Hoth and Penner, 1992 ) (unless it is rapidly desensitising; Fonteriz et al., 1992) .
Moreover, Mn2+ quenching of fura-2 also gave some insight into how ionomycin stimulates Mn2+ uptake: it could be envisaged that either ionomycin acts as a 'Mn2+ ionophore' (a direct translocation across the plasma membrane), or that it stimulates influx by SRCE. Therefore it is noteworthy that the maximal rate of quench established after complete discharge of the stores with histamine was not increased further by ionomycin, suggesting that ionomycin did not provide an additional route of entry across the plasma membrane. In addition to this, Mn2+ entry was still seen after ionomycin wash-out, indicating that ionomycin did not need to be present (at least at concentrations that elevate [Ca2+]i) for influx to occur. In further support of a SRCE mechanism, either refilling of internal stores with Ca2+ or treatment with SK&F 96365 could almost completely abolish ionomycin-stimulated Mn2+ entry. lonomycin not being a true Mn2+ ionophore is consistent with previous data where thrombin inhibited both histamine-and ionomycin-stimulated Mn2+ influx, suggesting a common mechanism of Mn2+ entry (Neylon and Irvine, 1991) . It is also consistent with ionophores activating similar inward cation conductances to agonists in whole-cell recordings in HUVEC (Bregetovski et al., 1988 (Albert and Tashjian, 1984) or cell swelling (Artalejo and Garcia-Sancho, 1988) [Ca2+], in the presence of micromolar levels of ionomycin ( Figure   6 ).
Secondly, channel antagonists can be used to discriminate between store-regulated Ca2+ entry and ionophore action at the plasma membrane. Although transition-metal ions are commonly employed as non-specific blockers of Ca2+ entry (Rink, 1990) , their potential for competing with Ca2+ for the co-ordination sites in the ionomycin molecule (Stiles et al., 1991) rendered them unsuitable agents. Instead, the store-regulated Ca2+-entry blocker SK&F 96365 was used (Merritt et al., 1990; Davies et al., 1992; Schilling et al., 1992; Graier et al., 1992) (Schilling et al., 1992) or FRTL cells (Tornquist, 1993) and of other SRCE blockers on the store-dependent effects of ionomycin, thapsigargin and CPA (Alonso et al., 1991; Sargeant et al., 1992; Vostal and Fratantoni, 1993) .
Thirdly, in additivity experiments, the ionomycin enhancement of the histamine response was abolished by treatment with CPA ( Figure 6 ). Although it might be argued that the CPA-raised baseline before histamine stimulation may have activated extrusion mechanisms that obscured elevations in [Ca21] (Irvine, 1992; ].
Very recently, Mason and Grinstein (1993) Cabello and Schilling (1993) , the route of cation entry into the cytoplasm of vascular endothelial cells had not been entirely resolved. In agreement with their conclusion, our data also suggest that cations enter the cytoplasm directly rather than passing into the store via a restricted channel (Merritt and Rink, 1987) . Firstly, histamine did not potentiate the Mn2+ quench evoked by either ionomycin or CPA. As argued by Putney for Ca2l (Takemura et al., 1989) , if Mn2' enters the cytoplasm from the store via a leak pathway, then activation of the InsP3 receptor upon addition of histamine would enhance the rate of quench by providing an additional route from the store to the cytoplasm, since the InsP3-receptor channel conducts Mn2+ ions (Glennon et al., 1992; Joseph and Williamson, 1986 antagonised by pyrilamine (Figure 7 ). This can be explained in two ways: either (i) Ca2+ enters the cytoplasm directly via a restricted space or (ii) there is a direct entry into the internal pool, but there must also be a considerable and rapid leak pathway from the store to the cytoplasm (unlikely to be the activated InsP3 receptor, since histamine stimulation of phospholipase C was removed). However, the elevation of [Ca2+]1 with CPA appears to be due to a slow leak from stores, and not from an inherently slow model of action (A. J. Morgan and R. Jacob, unpublished work). Such a slow leak (maximum initial rate 0.0095 + 0.0009 uM/s; n = 15) could not account for the rate of rise in [Ca2+]1 (_ 10-fold greater) produced on replenishing Ca2+0. The results are more consistent with Ca2+ directly entering the cytoplasm into a restricted domain below the plasma membrane (Putney, 1986 (Putney, , 1990 Cabello and Schilling, 1993) , where it is rapidly sequestered into the intracellular stores by a Ca2+_ ATPase (Luckhoff and Busse, 1990) .
We have demonstrated that ionomycin predominantly stimulates cation entry indirectly by activation of SRCE, not by a direct translocation across the plasma membrane. The data also further support the hypothesis that cations do not first enter endothelial cells via the internal stores, but by a direct route into the cytoplasm (Putney, 1986 (Putney, , 1990 . Although our evidence strongly suggests a selectivity of ionomycin for endomembranes [as has previously been only hinted at (Stauderman and Pruss, 1989; Albert and Tashjian, 1986; Neylon and Irvine, 1991) ], there are reports of ionophore being unaffected by conditions which can nevertheless blunt the agonist-stimulated Ca2+ entry (McCarthy et al., 1989; Davies et al., 1992; Graier et al., 1992) . We cannot fully explain such discrepancies in the light of our data, but suggest that there may be differences in experimental protocols (e.g. relative concentration of ionophores or Mn2+) or in agonist-specific pathways in these systems. Why ionomycin should selectively act on internal membranes is unclear, but ionic or pH differences may induce variations in the affinity of ionomycin for Ca2+ (Fasalato and Pozzan, 1989) . The ability of ionomycin to mobilize selectively intracellular Ca2+ by an alternative mechanism to InsP, elevation or Ca2+-ATPase inhibition could provide a useful tool for investigating Ca2+i regulation.
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